SigmaTron International, Inc. short interest in 2022
In 2022, SigmaTron International, Inc.'s disclosed short interest ran from 5.50% of shares outstanding on 31 Mar 2022 to 2.97% on 30 Dec 2022, a change of -2.53 percentage points. The year's high was 5.68% on 14 Apr 2022 and its low 2.97% on 30 Nov 2022, averaging 3.90% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.82 days on 15 Sep 2022. Full history: SigmaTron International, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2022 in figures
- Start of year
- 5.50% (31 Mar 2022)
- End of year
- 2.97% (30 Dec 2022)
- Change
- -2.53 pp
- High
- 5.68% (14 Apr 2022)
- Low
- 2.97% (30 Nov 2022)
- Average
- 3.90%
- Highest days to cover
- 14.82 (15 Sep 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 31 Mar 2022 | 5.50% | 1.63 | results (8-K), 10-Q filed |
| 14 Apr 2022 | 5.68% | 4.23 | |
| 29 Apr 2022 | 4.72% | 7.36 | |
| 13 May 2022 | 4.64% | 4.55 | |
| 31 May 2022 | 5.24% | 8.21 | |
| 15 Jun 2022 | 4.46% | 8.45 | |
| 30 Jun 2022 | 4.40% | 11.78 | |
| 15 Jul 2022 | 3.75% | 11.81 | |
| 29 Jul 2022 | 3.89% | 8.29 | 10-K filed, results (8-K) |
| 15 Aug 2022 | 3.38% | 11.56 | |
| 31 Aug 2022 | 3.32% | 12.45 | |
| 15 Sep 2022 | 3.40% | 14.82 | results (8-K), 10-Q filed |
| 30 Sep 2022 | 3.27% | 7.52 | |
| 14 Oct 2022 | 3.25% | 14.61 | |
| 31 Oct 2022 | 3.16% | 12.03 | |
| 15 Nov 2022 | 3.06% | 13.07 | |
| 30 Nov 2022 | 2.97% | 10.52 | |
| 15 Dec 2022 | 3.01% | 6.81 | results (8-K), 10-Q filed |
| 30 Dec 2022 | 2.97% | 3.90 |
See also: SigmaTron International, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.